Publikationen, an denen er mitarbeitet Miguel López Botet (3)

2021

  1. CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function

    Cancer Immunology Research, Vol. 9, Núm. 12, pp. 1476-1490

2019

  1. Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

    OncoImmunology, Vol. 8, Núm. 7

2017

  1. Targeting NK-cell checkpoints for cancer immunotherapy

    Current Opinion in Immunology, Vol. 45, pp. 73-81